USPH
$73.86-0.47 (-0.63%)
U.S.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
U.S. Physical Therapy, Inc. operates and manages outpatient physical therapy clinics. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care a...
Recent News
A Look At U.S. Physical Therapy’s Valuation As Guidance Rises On Revenue Growth And Record Clinic Volumes
U.S. Physical Therapy (USPH) recently raised its full year adjusted EBITDA guidance after reporting record clinic volumes and double digit revenue growth across both physical therapy and injury prevention, prompting investors to reassess the stock’s risk reward profile. See our latest analysis for U.S. Physical Therapy. Despite the uplift in guidance and record clinic volumes, the recent news flow around higher full year adjusted EBITDA, new hospital alliances, a modest dividend increase and...
1 Russell 2000 Stock with Exciting Potential and 2 We Avoid
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
$9 Million Exit: Investor Dumps 110,000 Shares of U.S. Physical Therapy as Stock Lags Broader Market
This healthcare firm delivers outpatient therapy and injury prevention services to individuals and corporate clients across the U.S.
Outpatient & Specialty Care Stocks Q4 In Review: U.S. Physical Therapy (NYSE:USPH) Vs Peers
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the outpatient & specialty care industry, including U.S. Physical Therapy (NYSE:USPH) and its peers.
Wall Street Analysts Believe U.S. Physical Therapy (USPH) Could Rally 26.52%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in U.S. Physical Therapy (USPH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.